Cardiovascular risk factors during sequentially combined 17β oestradiol and dydrogesterone (Femoston®); results from a one-year study in postmenopausal women-Reference-Cited by-同舟云学术

Cardiovascular risk factors during sequentially combined 17β oestradiol and dydrogesterone (Femoston®); results from a one-year study in postmenopausal women

Published:1997-03 Issue:2 Volume:26 Page:125-132
ISSN:0378-5122
Container-title:Maturitas
language:en
Short-container-title:Maturitas

Author:

Gelfand M.,Fugère P.,Bissonnette F.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,General Biochemistry, Genetics and Molecular Biology

Reference40 articles.

1. Influence of age and menopause on serum lipids and lipoproteins in healthy women;Stevenson;Atherosclerosis,1993

2. Perimenopausal increase in serum cholesterol: a 10-year longitudinal study;van Beresteijn;Am J Epidemiol,1993

3. Estrogen therapy and cardiovascular disease: do the benefits outweigh the risks?;Bush;Clin Obstet Gynecol,1991

4. Estrogen and coronary heart disease in women;Barrett-Connor;JAMA,1991

5. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study;Bush;Circulation,1987

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endothelin-1-induced hypertrophic alterations and heme oxygenase-1 expression in cardiomyoblasts are counteracted by beta estradiol: in vitro and in vivo studies;Naunyn-Schmiedeberg's Archives of Pharmacology;2018-01-21

2. MENOPAUSAL HORMONE THERAPY WITH DYDROGESTERONE: ASPECTS OF EFFICACY AND SAFETY OF ULTRA-LOW DOSES;Medical Council;2017-12-30

3. Oral estradiol and dydrogesterone combination therapy in postmenopausal women: Review of efficacy and safety;Maturitas;2013-09

4. Short-term effects of two continuous combined oestrogen–progestogen therapies on several cardiovascular risk markers in healthy postmenopausal women: A randomised controlled trial;European Journal of Obstetrics & Gynecology and Reproductive Biology;2009-02

5. Estrogen-progestin therapy in women after stem cell transplant;Menopause;2007-03